[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100590055":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":35,"locations":41,"responsibleParty":113,"collaborators":26,"id":116,"slug":26,"hasResults":117,"nctId":118,"briefTitle":119,"officialTitle":120,"acronym":26,"eligibilityCriteria":121,"healthyVolunteers":117,"sex":122,"minAge":123,"maxAge":26,"enrollmentInfo":124,"targetDuration":26,"studyType":127,"phases":128,"briefSummary":130,"conditions":131,"keywords":26,"overallStatus":44,"whyStopped":26,"lastUpdateSubmitDate":133,"lastUpdatePostDateStruct":134,"startDateStruct":137,"completionDateStruct":139,"leadSponsor":141,"locationsCount":142},{"fullName":5,"class":6},"Shanghai Chest Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"RAB group","EXPERIMENTAL","The eligible patient will be diagnosed using the robotic bronchoscopy system and catheters developed by Changzhou Langhe Medical Devices Co., Ltd.",[13],"Device: Robotic bronchoscopy system",{"label":15,"type":16,"description":17,"interventionNames":18},"UB-VBN group","ACTIVE_COMPARATOR","The eligible patient will be diagnosed using ultrathin bronchoscope combined with virtual bronchoscopic navigation.",[19],"Device: Ultrathin bronchoscope combined with virtual bronchoscopic navigation",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","Robotic bronchoscopy system","Utilization of a robotic bronchoscopy system for the biopsy of patients with peripheral pulmonary lesions suspected of malignancy",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Ultrathin bronchoscope combined with virtual bronchoscopic navigation","Utilization of ultrathin bronchoscope combined with virtual bronchoscopic navigation for the biopsy of patients with peripheral pulmonary lesions suspected of malignancy",[15],[32],{"name":33,"affiliation":5,"role":34},"Jiayuan Sun","STUDY_DIRECTOR",[36],{"name":37,"role":38,"phone":39,"phoneExt":26,"email":40},"Xiaoxuan Zheng","CONTACT","18930859598","milozheng9140@163.com",[42,61,76,87,98],{"facility":43,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"Shandong Public Health Clinical Center","RECRUITING","Jinan","Shandong","250000","China","CN",{"type":51,"coordinates":52},"Point",[53,54],116.99722,36.66833,{"lat":54,"lon":53},[57],{"name":58,"role":38,"phone":59,"phoneExt":26,"email":60},"Xiaopin Wang, PhD","86-0531-86568019","jinan5823@126.com",{"facility":62,"status":44,"city":63,"state":64,"zip":65,"country":48,"countryCode":49,"cosmosGeoPoint":66,"geoPoint":70,"contacts":71},"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine","Shanghai","Shanghai Municipality","200025",{"type":51,"coordinates":67},[68,69],121.45806,31.22222,{"lat":69,"lon":68},[72],{"name":73,"role":38,"phone":74,"phoneExt":26,"email":75},"Wei CHEN, PHD","021-64370045","cw11242@rjh.com.cn",{"facility":5,"status":44,"city":63,"state":64,"zip":77,"country":48,"countryCode":49,"cosmosGeoPoint":78,"geoPoint":80,"contacts":81},"200030",{"type":51,"coordinates":79},[68,69],{"lat":69,"lon":68},[82],{"name":83,"role":38,"phone":84,"phoneExt":85,"email":86},"Jiayuan Sun, PhD","86-21-22200000","1511","jysun1976@163.com",{"facility":88,"status":44,"city":63,"state":64,"zip":89,"country":48,"countryCode":49,"cosmosGeoPoint":90,"geoPoint":92,"contacts":93},"Zhongshan Hospital，Fudan University","200032",{"type":51,"coordinates":91},[68,69],{"lat":69,"lon":68},[94],{"name":95,"role":38,"phone":96,"phoneExt":26,"email":97},"Chun Li, MD","86-21-64041990","li.chun@zs-hospital.sh.cn",{"facility":99,"status":44,"city":100,"state":101,"zip":102,"country":48,"countryCode":49,"cosmosGeoPoint":103,"geoPoint":107,"contacts":108},"Sir Run Run Shaw Hospital , affiliated with the Zhejiang University School of Medicine","Hangzhou","Zhejiang","310016",{"type":51,"coordinates":104},[105,106],120.16142,30.29365,{"lat":106,"lon":105},[109],{"name":110,"role":38,"phone":111,"phoneExt":26,"email":112},"Enguo Chen, PhD","0571-87887890","3195024@zju.edu.cn",{"type":114,"investigatorFullName":33,"investigatorTitle":115,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"PRINCIPAL_INVESTIGATOR","Deputy Hospital Director","100590055",false,"NCT06962436","RAB Versus Ultrathin Bronchoscopy With VBN in the Diagnosis of PPNs","Robotic-Assisted Bronchoscopy Versus Ultrathin Bronchoscope Combined With Virtual Bronchoscopic Navigation for the Diagnosis of Peripheral Pulmonary Nodules: A Prospective, Multicenter, Randomized Controlled，Non-inferiority Clinical Study","Inclusion Criteria:\n\n1. Age ≥ 18 years, regardless of gender;\n2. Patients with peripheral lung nodules of suspected malignancy on chest CT who require non-surgical biopsy;\n3. Patients who voluntarily consent to undergo bronchoscopy and meet the requirements for the bronchoscopy;\n4. Patients should understand the purpose of the trial, demonstrate good compliance with the examinations and follow-ups, and voluntarily participate in the clinical trial and sign the informed consent form.\n\nExclusion Criteria:\n\n1. Presence of contraindications for bronchoscopy, including: active massive hemoptysis; recent myocardial infarction or unstable angina; severe cardiac or pulmonary dysfunction; severe hypertension and arrhythmias; uncorrectable bleeding tendencies or severe coagulation disorders (such as platelet count \\\u003C60×10\\^9\u002FL), uremia; severe pulmonary artery hypertension; severe superior vena cava syndrome; intracranial hypertension; acute cerebrovascular events; aortic dissection or aneurysm; multiple bullae; extreme systemic exhaustion;\n2. Patients with pure ground-glass nodules suspected of malignancy on chest CT;\n3. Female patients who are breastfeeding, pregnant, or planning pregnancy;\n4. Patients with electromagnetic active implantable medical devices;\n5. Subjects allergic to anesthetics; or with a history of multiple severe allergies, hereditary allergy history;\n6. Those who have participated in or are currently participating in drug clinical trials within 3 months before screening, or have participated in other medical device clinical trials within 30 days;\n7. Any other conditions deemed unsuitable for participation in this clinical trial by the investigator.","ALL","18 Years",{"count":125,"type":126},186,"ESTIMATED","INTERVENTIONAL",[129],"NA","The purpose of this study is to evaluate whether the diagnostic yield of robotic-assisted bronchoscopy is not inferior to that of the virtual bronchoscopic navigation combined with ultrathin bronchoscopy.",[132],"Peripheral Pulmonary Nodules","2026-03-20",{"date":135,"type":136},"2026-03-25","ACTUAL",{"date":138,"type":136},"2025-07-02",{"date":140,"type":126},"2026-12",{"name":5,"class":6},5]